Navigation Links
Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
Date:10/13/2008

NATICK, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Thursday and Friday of last week saw continued heavy trading in Boston Scientific's (NYSE: BSX) stock. As anticipated in the Company's October 9th news release, a significant portion of this trading was due to involuntary sales of shares beneficially owned by Boston Scientific's co-founders Pete Nicholas and John Abele. As of the close of the market on Friday, approximately 31 million shares in aggregate had been sold last week through involuntary sales related to collateralized loans of Mr. Nicholas and Mr. Abele, including nearly 13 million shares on Friday.

The Company believes there may be additional involuntary sales of shares beneficially owned by Mr. Nicholas and Mr. Abele over the next several weeks, but the Company estimates, based upon an assessment of the facts available to it and the price of the Company's stock at the close of business on Friday, October 10th, that the majority of the involuntary selling has already occurred.

"While these involuntary sales are certainly disappointing, it is important to keep in mind that the Company has approximately 1.5 billion shares outstanding and that even after the events of last week John Abele and I continue to collectively hold more than 90 million shares of Boston Scientific stock," said Nicholas. "Our confidence in the Company and its future is unwavering."

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements
'/>"/>

SOURCE Boston Scientific
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... 14 The third edition of ... , published by the Infusion Nurses Society ... anthracycline extravasation.(1) Anthracyclines are a group of ... that have been used in the treatment of ... ,, According to the INS publication: ...
(Date:12/14/2009)... 14 Lionbridge (Nasdaq: LIOX ... a new, three-year master services agreement with ... and services that serve patients in approximately ... become the sole provider for translation of ... marketing, training, human resources, legal, and corporate ...
(Date:12/14/2009)... 14 Decision Resources, one of the ... and healthcare issues, finds that, owing to the ... drug market will increase more than sevenfold from ... 2018 in the United States, France, Germany, Italy, ... new Pharmacor report entitled Atrial Fibrillation ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... Belgium, AHMEDABAD, India and GOTTINGEN, Germany,October 6 ... Aalst and J.B. Dahm, MD have reached ... venture, called imaeon., imaeon initially will ... for clinical research projects, including but not ...
... to focus on a new dietary supplement resulting from years of, ... ... Del-Immune V, BOULDER, Colo., Oct. 6 ... "Immune regulatory,cytokines Del-Immune V(R) induction and its impact on cytotoxicity of,natural killer ...
... Ziehm Imaging and BrainLAB Improve Intra-Operative Imaging With Navigation ... for More ... October 6 Ziehm Imaging,and BrainLAB have developed the ... x-ray based navigation for spinal and trauma,surgery. The two ...
Other Biology Technology:Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm 2EUPROBIO 2008 Presentation to Highlight Latest Immune Research 2New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D 2New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D 3
(Date:12/11/2009)... Scientists studying how bacteria under stress collectively weigh and ... insights into how humans make strategic decisions that affect ... society. , Their study, published this week in the ... the National Academy of Sciences , was accomplished when ... to describe the complex interplay of genes and proteins ...
(Date:12/11/2009)... For nearly two decades, Ivy Pike, an associate professor ... studying ethnic groups in rural northern Kenya to understand ... a living there. , The results of her and ... warfare in three pastoralist communities of northern Kenya: A ... of Social Science and Medicine , in collaboration ...
(Date:12/11/2009)... of the 4th edition of Springer,s classic reference and ... the Victor A. McKusick Leadership Award. The prize, which ... human genetics, was presented to him at the 59th ... on 24 October 2009 in Honolulu, Hawaii. , Motulsky ... the University of Washington in Seattle. One of the ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Tyco International to Present at the Citi Industrial Manufacturing 26amp 3B Transportation Conference 60962 1Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference 60960 1BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to 24665 Million 14767 1BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to 24665 Million 14767 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to 24665 Million 14767 3
... of mutations that disrupt the function of a gene and ... of an "illegitimate" microRNA (miRNA) recognition site in a gene ... In this study, the gene concerned is the myostatin. This ... of the derived protein is to inhibit muscular growth. The ...
... of their parents may give birds a preference for ... more exactly match those of their parents. Such learned ... traits and strong morphological differences between sexes ?phenomena seen ... reported by Carel ten Cate, Machteld Verzijden and Eric ...
... a strong-boned rat that can't be broken. But a ... citrus juice. , Orange and grapefruit juice regularly given ... aging disease in which bones become more likely to ... Vegetable and Fruit Improvement Center researchers. The article was ...
Other Biology News:Zebra finch males prefer females with exaggerated maternal traits 2Orange, grapefruit juice for breakfast builds bones in rats 2
... Phosphothioate (PTO) oligonucleotides: PTOs ... in the phosphate backbone is replaced by ... oligonucleotide against nuclease degradation. PTOs are available ... linkages are phosphothioates Oligonucleotides with thio-caps ...
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
... For microsatellite research, the 4300 System features ... automation software available. SagaGT automates electrophoresis, lane ... sizes, and allele scoring. ,Saga GT ... Saga 1.0 (Unix) was initially developed at ...
MOUSE ANTI GTP BINDING PROTEIN...
Biology Products: